Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds

溶瘤病毒 医学 放射治疗 脑瘤 肿瘤微环境 胶质母细胞瘤 免疫疗法 癌症研究 生物信息学 神经科学 免疫系统 免疫学 生物 内科学 病理
作者
Sweety Asija,Abhishek Chatterjee,Sandhya Yadav,Godhanjali Chekuri,Atharva Karulkar,Ankesh Kumar Jaiswal,Jayant Sastri Goda,Rahul Purwar
出处
期刊:International Reviews of Immunology [Taylor & Francis]
卷期号:41 (6): 582-605 被引量:26
标识
DOI:10.1080/08830185.2022.2101647
摘要

The aggressive and recurrent nature of glioblastoma is multifactorial and has been attributed to its biological heterogeneity, dysfunctional metabolic signaling pathways, rigid blood–brain barrier, inherent resistance to standard therapy due to the stemness property of the gliomas cells, immunosuppressive tumor microenvironment, hypoxia and neoangiogenesis which are very well orchestrated and create the tumor's own highly pro-tumorigenic milieu. Once the relay of events starts amongst these components, eventually it becomes difficult to control the cascade using only the balanced contemporary care of treatment consisting of maximal resection, radiotherapy and chemotherapy with temozolamide. Over the past few decades, implementation of contemporary treatment modalities has shown benefit to some extent, but no significant overall survival benefit is achieved. Therefore, there is an unmet need for advanced multifaceted combinatorial strategies. Recent advances in molecular biology, development of innovative therapeutics and novel delivery platforms over the years has resulted in a paradigm shift in gliomas therapeutics. Decades of research has led to emergence of several treatment molecules, including immunotherapies such as immune checkpoint blockade, oncolytic virotherapy, adoptive cell therapy, nanoparticles, CED and BNCT, each with the unique proficiency to overcome the mentioned challenges, present research. Recent years are seeing innovative combinatorial strategies to overcome the multifactorial resistance put forth by the GBM cell and its TME. This review discusses the contemporary and the investigational combinatorial strategies being employed to treat GBM and summarizes the evidence accumulated till date.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
杨一完成签到,获得积分10
1秒前
科研通AI6.4的应助被大吱吱采纳,获得10
1秒前
大气的莆完成签到,获得积分10
2秒前
2秒前
3秒前
cheng完成签到,获得积分10
3秒前
3秒前
qz关闭了qz的文献求助
3秒前
3秒前
NN发布了新的文献求助30
4秒前
Irene发布了新的文献求助10
4秒前
4秒前
4秒前
陈陈陈完成签到 ,获得积分10
5秒前
llllll完成签到,获得积分20
5秒前
6秒前
浮生绘完成签到,获得积分10
6秒前
cheng发布了新的文献求助10
6秒前
所所的应助被Atue采纳,获得10
7秒前
7秒前
7秒前
elvira的应助被舒适的秋尽采纳,获得10
7秒前
CodeCraft的应助被kuaikuai采纳,获得10
7秒前
8秒前
丘比特的应助被Irene采纳,获得10
8秒前
JamesPei的应助被shidewu采纳,获得10
8秒前
9秒前
9秒前
搜集达人的应助被张张采纳,获得10
9秒前
不安易文发布了新的文献求助10
10秒前
jiajiajai完成签到,获得积分10
10秒前
Youzi完成签到,获得积分10
10秒前
无花果的应助被玩家666采纳,获得10
10秒前
科研小白发布了新的文献求助10
11秒前
过几天发布了新的文献求助10
12秒前
JamesPei的应助被小太阳采纳,获得10
12秒前
wby完成签到 ,获得积分10
13秒前
叶95发布了新的文献求助10
13秒前
苗条梨愁发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178484
求助须知:如何正确求助?哪些是违规求助? 9569318
关于积分的说明 21803439
捐赠科研通 7773381
什么是DOI,文献DOI怎么找? 3432819
关于科研通互助平台的介绍 2556838
邀请新用户注册赠送积分活动 2478441